1. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
   Weixing Dai et al, 2022, Cancer Communications CrossRef
2. LncRNA HULC promotes lung squamous cell carcinoma by regulating PTPRO via NF‐κB
   Yang Xu et al, 2019, Journal of Cellular Biochemistry CrossRef
3. Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
   Zhimeng Yao et al, 2023, JCI Insight CrossRef
4. Mouse models in squamous cell lung cancer: impact for drug discovery
   Aditi P. Singh et al, 2018, Expert Opinion on Drug Discovery CrossRef
5. Oestrogen inhibits PTPRO to prevent the apoptosis of renal podocytes
   Wei Ren et al, 2019, Experimental and Therapeutic Medicine CrossRef
6. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR
   Yue-ya Liang et al, 2018, World Journal of Surgical Oncology CrossRef
7. PTPRO knockdown protects against inflammation in hemorrhage shock-induced lung injury involving the NF-κB signaling pathway
   Zhirong Huan et al, 2022, Respiratory Research CrossRef
8. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
   Riccardo Nevola et al, 2023, Biology CrossRef
9. Identification and validation of miRNA-target genes network in pediatric brain tumors
   Renata Gruszka et al, 2024, Scientific Reports CrossRef
10. Protein tyrosine phosphatase receptor type O (PTPRO) knockdown enhances the proliferative, invasive and angiogenic activities of trophoblast cells by suppressing ER resident protein 44 (ERp44) expression in preeclampsia
    Yang Yang et al, 2021, Bioengineered CrossRef
11. Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
    Hongmei Dong et al, 2022, Frontiers in Pharmacology CrossRef